跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ipodex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ipodex
Approved
STANDARD
Ipodex
Egyptian International Pharmaceutical Industries Co. (EIPICO)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
51d7a2d6a5cb52f1
Company
Egyptian International Pharmaceutical Industries Co. (EIPICO)
Type
Standard
Approval Details
Approval Id
51d7a2d6a5cb52f1
Drug Approval Philippines Name
Ipodex
Product Name
Ipodex
Registration Number
DRP-7734-03
Brand Name
Ipodex
Generic Name
Dexamethasone + Neomycin (as Sulfate) + Polymyxin-B-Sulfate
Dosage Form
Ophthalmic and Otic Suspension
Dosage Strength
1 mg/ 3.5 mg / 6000 I.U.
Manufacturer
Egyptian International Pharmaceutical Industries Co. (EIPICO)
Importer
Ambica International Corporation
Distributor
I-Senz Medical Inc
Issuance Date
25 August 2022
Expiry Date
16 March 2028
Pharmacologic Category
Corticosteroid / Anti-infective
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
51d7a2d6a5cb52f1
Type
Standard
Back to Philippines FDA Approvals